Social Network Bolsters Teen Emotions After Suicide BombingsJerusalem Post -- BGU researchers discover that teenagers who have a strong social support system are more resilient to depression after being exposed to terrorism-related stress.
BGU Researchers Discover Treatment for Brain Trauma-induced ...Dr. Alon Friedman, a neurosurgeon, professor and researcher at Ben-Gurion University of the Negev, working with researchers from UC Berkeley, California have identified a TGF Beta Blocker that when given to rats prevents epilepsy after brain damage, according to a new study appearing in the July 15 issue of The Journal of Neuroscience.
BGU Researchers Identify How “Stressed” Fat Tissue ...BGU Researchers Identify How “Stressed” Fat Tissue Malfunctions and Contributes to Obesity-Associated Diseases.
Did Evolution Make Us Cancer Prone?The Jerusalem Post -- Researchers at BGU���s National Institute for Biotechnology in the Negev suspect human mutations during evolution play a role in our susceptibility to cancer.
Canker Sores in Mouth Caused by Unknown VirusThe Palm Beach Post -- BGU researchers have discovered that a nightly dose of vitamin B12 is a simple, effective and low-risk therapy to prevent recurrent "canker sores."
Drug Appears Safe for Morning SicknessThe New York Times -- BGU researchers performed one of the largest studies ever done on a commonly used anti-nausea drug to conclude it is safe to use during pregnancy.
Study Finds Little Risk From a Morning Sickness MedicationLos Angeles Times -- BGU researchers ease the minds of pregnant women with their study showing no risk to fetuses when using a popular morning sickness medication.
Off-Label Morning Sickness Drug Deemed Safe for FetusesOff-label morning sickness drug, Metoclopramide, poses no significant risks to the fetus according to a large collaborative study by researchers and physicians at Ben-Gurion University of the Negev, Soroka University Medical Center, Clalit Health Services, and the Division of Pharmacology, Hospital for Sick Children in Toronto. The results were published in the June 11 issue of the prestigious New England Journal of Medicine.
Morning Sickness Drug Gets Green Light in StudyU.S. News &
back to previous page